Mirae Asset Global Investments’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$69.1K Buy
4,042
+819
+25% +$14K ﹤0.01% 1204
2025
Q1
$227K Sell
3,223
-3,347
-51% -$236K ﹤0.01% 1029
2024
Q4
$797K Buy
6,570
+568
+9% +$68.9K ﹤0.01% 865
2024
Q3
$747K Buy
6,002
+3,180
+113% +$396K ﹤0.01% 879
2024
Q2
$446K Sell
2,822
-88,123
-97% -$13.9M ﹤0.01% 936
2024
Q1
$12.1M Buy
90,945
+47,895
+111% +$6.39M 0.03% 558
2023
Q4
$4.15M Sell
43,050
-52,815
-55% -$5.09M 0.01% 940
2023
Q3
$11.6M Buy
95,865
+4,763
+5% +$577K 0.03% 559
2023
Q2
$10.4M Sell
91,102
-1,361
-1% -$156K 0.02% 628
2023
Q1
$12.7M Buy
92,463
+4,080
+5% +$562K 0.03% 540
2022
Q4
$11.5M Sell
88,383
-37,147
-30% -$4.81M 0.03% 551
2022
Q3
$13.9M Buy
125,530
+11,908
+10% +$1.32M 0.04% 453
2022
Q2
$8.52M Sell
113,622
-19,781
-15% -$1.48M 0.02% 658
2022
Q1
$10.4M Sell
133,403
-21,768
-14% -$1.7M 0.02% 657
2021
Q4
$14M Sell
155,171
-20,226
-12% -$1.82M 0.03% 573
2021
Q3
$16.2M Buy
175,397
+33,424
+24% +$3.09M 0.04% 464
2021
Q2
$11M Buy
141,973
+85,670
+152% +$6.66M 0.03% 590
2021
Q1
$4.2M Buy
56,303
+24,143
+75% +$1.8M 0.01% 767
2020
Q4
$5.48M Buy
32,160
+8,724
+37% +$1.49M 0.02% 631
2020
Q3
$3.29M Buy
23,436
+6,092
+35% +$855K 0.02% 636
2020
Q2
$2.78M Buy
17,344
+2,046
+13% +$328K 0.02% 624
2020
Q1
$1.5M Buy
15,298
+2,400
+19% +$235K 0.01% 721
2019
Q4
$1.66M Buy
12,898
+3,838
+42% +$495K 0.01% 794
2019
Q3
$682K Buy
9,060
+3,286
+57% +$247K ﹤0.01% 1059
2019
Q2
$877K Buy
5,774
+1,579
+38% +$240K 0.01% 954
2019
Q1
$500K Buy
+4,195
New +$500K ﹤0.01% 1042